Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CSIR, Laxai Life Sciences get DCGI nod for clinical trials of Colchicine on COVID-19 patients

expresspharmaJune 15, 2021

Tag: CSIR , Laxai Life Sciences , DCGI , colchicine

PharmaSources Customer Service